Creative Planning - PROVECTUS BIOPHARMACEUTICALS ownership

PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 8 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Creative Planning ownership history of PROVECTUS BIOPHARMACEUTICALS
ValueSharesWeighting
Q3 2016$11,000
-62.1%
111,953
+42.0%
0.00%
Q2 2016$29,000
-3.3%
78,8180.0%0.00%
Q1 2016$30,000
-6.2%
78,818
-3.7%
0.00%
Q4 2015$32,000
-28.9%
81,818
+3.8%
0.00%
Q3 2015$45,000
-25.0%
78,818
-29.5%
0.00%
-100.0%
Q2 2015$60,000
-18.9%
111,818
+23.7%
0.00%0.0%
Q1 2015$74,000
+23.3%
90,400
+19.9%
0.00%0.0%
Q4 2014$60,000
+20.0%
75,400
+54.2%
0.00%0.0%
Q3 2014$50,000
+85.2%
48,900
+55.7%
0.00%
Q2 2014$27,00031,4000.00%
Other shareholders
PROVECTUS BIOPHARMACEUTICALS shareholders Q4 2016
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 79,500$2,0000.00%
HOME FEDERAL BANK OF TENNESSEE 100,000$2,0000.00%
FINANCIAL COUNSELORS INC 12,600$00.00%
Focused Wealth Management, Inc 2,955$00.00%
GLENMEDE TRUST CO NA 5,000$00.00%
PRINCETON CAPITAL MANAGEMENT LLC 10,000$00.00%
Bellwether Investment Group, LLC 350$00.00%
HUNTINGTON NATIONAL BANK 200$00.00%
View complete list of PROVECTUS BIOPHARMACEUTICALS shareholders